Attachment_7_-_Sample_Client_Authorization_Letter.pdf

PDF 17 KB Posted

Attached to
Animal Care, Technical Procedures, Formulation, and Veterinary Care Services
Solicitation number
16-223-SOL-00036
Issued by

About this file

Attachment 7 - Sample Client Authorization Letter

View the file

Other files

Show all 14

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

16-223-SOL-00036 ATTACHMENT 7

SAMPLE CLIENT AUTHORIZATION LETTER

(Transfer to Company Letterhead)

Dear Client, We are currently responding to Solicitation Number 16-223-SOL-00036 for On-site Animal Care, Technical Procedures, Formulation, and Veterinary Care Services at the Food and Drug Administration (FDA), Jefferson Laboratories Complex, National Center for Toxicological Research (NCTR), Jefferson, Arkansas.

The FDA placed emphasis on past performance as a key source selection factor and requires that clients of entities responding to the solicitations be identified and their participation in the evaluation process be requested.

Therefore, enclosed is a Present and Past Performance Questionnaire for your completion. We are requesting that you complete the questionnaire and send it directly to the Food and Drug Administration at the following address:

Food and Drug Administration Jefferson Laboratories Complex National Center for Toxicological Research Division of Acquisition Programs Field Operation Branch, HFT-320 Attn: Suzanne Martella 3900 NCTR Road, Bldg 50, Rm 430 Jefferson, AR 72079

Respondents may also fax the questionnaire to Suzanne Martella at 870-543-7990 or submit by email to suzanne.martella@fda.hhs.gov. Questionnaires must be received at the Agency no later than November 10, 2016.

If you have questions or require assistance regarding the attached questionnaire, please contact Suzanne Martella, FDA Contract Specialist, at 870-543-7540 or at suzanne.martella@fda.hhs.gov .

We thank you for your prompt response in this matter.

Sincerely, {Offering Entity} mailto:suzanne.martella@fda.hhs.gov mailto:suzanne.martella@fda.hhs.gov

File details come from the government source that posted it. Updated .